GNTA

Genenta Science (GNTA)

Genenta Science SPA

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GNTA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/06	19:25	GlobeNewswire Inc.	Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider	NASDAQ:GNTA	Genenta Science SPA
2024/02/13	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GNTA	Genenta Science SPA
2024/02/08	19:00	GlobeNewswire Inc.	Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors	NASDAQ:GNTA	Genenta Science SPA
2023/10/21	05:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNTA	Genenta Science SPA
2023/09/06	20:00	GlobeNewswire Inc.	Genenta to Present at Upcoming Scientific and Investor Conferences	NASDAQ:GNTA	Genenta Science SPA
2023/07/28	16:00	GlobeNewswire Inc.	Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments	NASDAQ:GNTA	Genenta Science SPA
2023/06/29	20:00	GlobeNewswire Inc.	The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma	NASDAQ:GNTA	Genenta Science SPA
2023/05/25	19:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNTA	Genenta Science SPA
2023/05/16	20:00	GlobeNewswire Inc.	Genenta to Provide Update on Lead Product Temferon™	NASDAQ:GNTA	Genenta Science SPA
2023/05/13	06:13	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	NASDAQ:GNTA	Genenta Science SPA
2023/05/02	05:06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
2023/04/26	20:00	GlobeNewswire Inc.	Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing	NASDAQ:GNTA	Genenta Science SPA
2023/04/22	06:23	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:GNTA	Genenta Science SPA
2023/03/11	06:49	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
2023/02/10	20:10	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GNTA	Genenta Science SPA
2023/02/02	07:29	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
2022/12/23	06:12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
2022/10/27	07:45	TipRanks	Maxim Group Remains a Buy on Genenta Science SpA Sponsored ADR (GNTA)	NASDAQ:GNTA	Genenta Science SPA
2022/10/26	06:14	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
2022/10/03	20:17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
2022/07/25	19:00	GlobeNewswire Inc.	AmCham Italy and Genenta Science Announce the Bowling Green Bull Initiative	NASDAQ:GNTA	Genenta Science SPA
2022/06/15	06:12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNTA	Genenta Science SPA
2009/06/15	23:47	PR Newswire (US)	The following is an investment opinion release issued by EmergingStockReport.com	NASDAQ:GNTA
2009/05/15	23:48	PR Newswire (US)	Stock Alerts on Market Movers: NGRN, RMBS, NVLS, LVS, GNTA, AN; Issued by Beacon Equity	NASDAQ:GNTA
2009/03/07	09:36	Dow Jones News	Genta: FDA Favors Clinical Trial For Leukemia Drug Genasense	NASDAQ:GNTA	Genta Inc.
2009/03/07	08:34	Business Wire	FDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory ...	NASDAQ:GNTA	Genenta Science SPA
2009/02/14	06:10	Business Wire	Genta Incorporated Announces Fourth Quarter and Year End 2008 Financial Results and Corporate Highlights	NASDAQ:GNTA	Genenta Science SPA
2009/01/08	03:02	PR Newswire (US)	Beacon Equity Issues Technical Trade Alerts on Newsworthy Market Movers: WLT, SSCC, FNSR, CHTR, STSI, GNTA	NASDAQ:GNTA
2008/09/15	21:05	PR Newswire (US)	Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma	NASDAQ:GNTA
2008/08/07	21:00	PR Newswire (US)	Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights	NASDAQ:GNTA